RecruitingNCT05485831

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

Studying Lennox-Gastaut syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Jazz Pharmaceuticals
Intervention
Epidiolex 100 mg/mL Oral Solution(drug)
Enrollment
100 enrolled
Eligibility
2 years · All sexes
Timeline
20252027

Study locations (18)

Collaborators

Advice Pharma Group srl

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05485831 on ClinicalTrials.gov

Other trials for Lennox-Gastaut syndrome

Additional recruiting or active studies for the same condition.

See all trials for Lennox-Gastaut syndrome

← Back to all trials